Insider Trading Activity Bruker Co. (NASDAQ:BRKR) – CEO Bought 4,300 shares of Stock

12

Insider Trading Activity For Bruker Co. (NASDAQ:BRKR)

Frank H Laukien , CEO of Bruker Co. (NASDAQ:BRKR) reportedly Bought 4,300 shares of the company’s stock at an average price of 23.34 for a total transaction amount of $100,362.00 SEC Form

Insider Trading History For Bruker Co. (NASDAQ:BRKR)

  • On 12/14/2012 Frank H Laukien, CEO, bought 50,000 with an average share price of $14.68 per share and the total transaction amounting to $734,000.00. View SEC Filing
  • On 2/25/2015 Frank H Laukien, CEO, bought 5,271 with an average share price of $18.95 per share and the total transaction amounting to $99,885.45. View SEC Filing
  • On 3/5/2015 Richard A Packer, Director, bought 15,000 with an average share price of $19.00 per share and the total transaction amounting to $285,000.00. View SEC Filing
  • On 3/17/2015 Charles F Wagner Jr, CFO, sold 19,000 with an average share price of $18.97 per share and the total transaction amounting to $360,430.00. View SEC Filing
  • On 6/11/2015 Stephen W Fesik, Director, sold 15,000 with an average share price of $20.48 per share and the total transaction amounting to $307,200.00. View SEC Filing
  • On 6/11/2015 Frank H Laukien, CEO, bought 5,901 with an average share price of $20.31 per share and the total transaction amounting to $119,849.31. View SEC Filing
  • On 6/15/2015 Frank H Laukien, CEO, bought 1,000,000 with an average share price of $19.50 per share and the total transaction amounting to $19,500,000.00. View SEC Filing
  • Analyst Ratings For Bruker Co. (NASDAQ:BRKR)
    These are 1 Sell Rating, 10 Hold Ratings, 3 Buy Ratings .
    The current consensus rating for Bruker Co. (NASDAQ:BRKR) is Hold (Score: 2.14) with a consensus target price of $24.27 , a potential (4.22% upside)

    Analyst Ratings History For Bruker Co. (NASDAQ:BRKR)

    • On 5/21/2015 William Blair Downgraded rating Outperform to Market Perform
    • On 8/27/2015 Maxim Group Initiated Coverage of rating Hold with a price target of $22.00
    • On 10/15/2015 Citigroup Inc Lower Price Target of rating Neutral with a price target of $22.00 to $20.00
    • On 1/6/2016 Avondale Partners Initiated Coverage of rating Market Perform with a price target of $26.00 with a price target of $24.00
    • On 3/14/2016 Stifel Nicolaus Boost Price Target of rating Buy with a price target of $25.00 to $32.00 with a price target of $21.00

    Dividend Information For Bruker Co. (NASDAQ:BRKR)
    Bruker Co. (NASDAQ:BRKR) pays an annual dividend of $0.16 with a yield of 0.69%

    Dividend History For Bruker Co. (NASDAQ:BRKR)

  • On 2/22/2016 Bruker Co. announced a Quarterly dividend of $0.04 with an ex dividend date of 3/2/2016 which will be payable on 3/24/2016.
  • On 5/18/2016 Bruker Co. announced a quarterly dividend of $0.04 0.61% with an ex dividend date of 6/2/2016 which will be payable on 6/24/2016.
  • On 8/9/2016 Bruker Co. announced a quarterly dividend of $0.04 0.72% with an ex dividend date of 9/1/2016 which will be payable on 9/23/2016.
  • On 11/15/2016 Bruker Co. announced a quarterly dividend of $0.04 0.69% with an ex dividend date of 12/1/2016 which will be payable on 12/23/2016.
  • On 2/21/2017 Bruker Co. announced a quarterly dividend of $0.04 0.65% with an ex dividend date of 3/6/2017 which will be payable on 3/24/2017.
  • About Bruker Co. (NASDAQ:BRKR)
    Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

    Recent Trading Activity for Bruker Co. (NASDAQ:BRKR)
    Shares of Bruker Co. closed the previous trading session at 23.23 down -0.06 -0.26% with 1,033,811 shares trading hands.

    An ad to help with our costs